Injectable Treatment for HIV Pre-Exposure Prevention

Nov. 15, 2022

PrEP (pre-exposure prophylaxis) can reduce your chances of getting HIV from sex or injection drug use. When taken as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. As of 2020, more than 25% of individuals who are at risk of HIV are taking PrEP. PrEP requires strict adherence, making the daily PrEP pill difficult for some individuals to consistently take. In 2021, the FDA approved Apretude, an injectable treatment for PrEP, for use in at-risk adults and adolescents weighing at least 77 pounds.  Apretude is given first as two injections administered one month apart, and then every two months thereafter. 

Most insurance plans and state Medicaid programs cover PrEP. Under the Affordable Care Act, PrEP must be free under almost all health insurance plans. That means you can’t be charged for your PrEP medication or the clinic visits and lab tests you need to maintain your prescription.

If you don’t have insurance or Medicaid coverage, there are other programs that provide PrEP for free or at a reduced cost: